Targeting cytokine signaling and lymphocyte traffic via small molecules in inflammatory bowel disease: JAK inhibitors and S1P receptor agonists https://priothera.com/targeting-cytokine-signaling-and-lymphocyte-traffic-via-small-molecules-in-inflammatory-bowel-disease-jak-inhibitors-and-s1pr-agonists/
S1P signaling: new therapies and opportunities https://priothera.com/s1p-signaling-new-therapies-and-opportunities/
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GvHD) https://priothera.com/insights-into-the-mechanism-of-fty720-and-compatibility-with-regulatory-t-cells-for-the-inhibition-of-graft-versus-host-disease-gvhd/
Recent Comments